Total planned funding: $64,173,058
Clear active filters
Democratic Republic of the Congo
HTXD: Treatment: ARV Drugs
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Democratic Republic of the Congo | $64,173,058 |
Organizational Types
Private Contractor | $63,661,608 |
Own Agency | $372,730 |
NGO | $113,019 |
Unknown | $19,116 |
Other USG Agency | $6,585 |
Multi-lateral Agency | $0 |
University | $0 |
FBO | $0 |
Program Areas
Treatment | $64,173,058 |
Budget Codes
HTXD: Treatment: ARV Drugs | $64,173,058 |
Top Partner Programs
Chemonics International:
$62,261,608
Countries/Regions
Democratic Republic of the Congo
2016 | $10,635,809 |
2018 | $11,556,778 |
2019 | $21,726,094 |
2020 | $18,342,927 |
Partnership for Supply Chain Management:
$1,400,000
Countries/Regions
Democratic Republic of the Congo
2013 | $1,400,000 |
USG Aggregated Agencies:
$224,794
Countries/Regions
Democratic Republic of the Congo
2016 | $109,546 |
2018 | $115,248 |
U.S. Agency for International Development:
$122,070
Countries/Regions
Democratic Republic of the Congo
2013 | $69,400 |
2019 | $52,670 |